Full Text
PCN59 THE POTENTIAL ECONOMIC BENEFITS PROVIDED BY COMBINING CISPLATIN WITH SRC INHIBITOR KX1-004 FOR CANCER REGIMENS

Abstract

Authors

D Henderson A Hayward C Purdy R Magar

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×